Food News and Research

RSS

Northwest Russian women breast milk consists of more POPs than Norwegian

Russian women living in Northwest Russia are more exposed to environmental toxins than Norwegian women. In spite of this, PhD candidate Anuschka Polder urges Russian women to breastfeed their babies.

22 Mar 2011

WHO concerned about radiation levels in food near damaged Japanese nuclear plant

A WHO spokesperson "said on Monday that the detection of radiation in food after an earthquake damaged a Japanese nuclear plant was a more serious problem than had first expected," Reuters reports.

22 Mar 2011

VirWall launches new UV sanitizer to eliminate bacteria, virus from communication devices

ViraShield, the new UV sanitizer introduced by VirWall Systems Inc., is the first multi-purpose device of its kind that takes only seconds to rid those products we've come to depend on of the bacteria and viruses that typically crawl, breed and cover the surfaces of our personal communications devices.

22 Mar 2011

Oral desensitization with omalizumab may treat milk allergy in children

Some 3 million children in the United States have some form of food allergy, ranging in severity from mild to life-threatening. Milk allergy is the most common, affecting 2.5 percent of children under age 3.

22 Mar 2011

High sodium intake may increase risk of heart disease, stroke, kidney problem

Taking in too much sodium may turn out to be quite a salty situation. In fact, according to the Centers for Disease Control and Prevention, in 2010 high blood pressure cost the United States $76.6 billion in health care services, medications, and missed days of work.

22 Mar 2011

Daily dose of safflower oil can help reduce cardiovascular disease

A daily dose of safflower oil, a common cooking oil, for 16 weeks can improve such health measures as good cholesterol, blood sugar, insulin sensitivity and inflammation in obese postmenopausal women who have Type 2 diabetes, according to new research.

22 Mar 2011

FDA accepts Arisaph's ARI-3037MO IND for phase I human clinical trial

Arisaph Pharmaceuticals, Inc., a privately held drug discovery biopharmaceutical company, today announced that the U.S. Food and Drug Administration has accepted the Company's recently submitted Investigational New Drug application to evaluate ARI-3037MO in a phase I human clinical trial in healthy volunteers.

22 Mar 2011

BMY's ipilimumab Phase III study against metastatic melanoma meets primary endpoint

Bristol-Myers Squibb Company today announced that a clinical trial -- known as study 024 -- of its investigational compound ipilimumab has met the primary endpoint of improving overall survival in previously-untreated patients with metastatic melanoma.

22 Mar 2011

Watson introduces Famciclovir tablets to treat cold sores, genital herpes

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. has launched Famciclovir tablets, 125 mg, 250 mg and 500 mg, the generic version of Novartis' Famvir following approval of its Abbreviated New Drug Application by the U.S. Food and Drug Administration.

22 Mar 2011

Doubts raised over Lap-Band surgery in the long term: Study

This surgery is based on the principle of placing a silicone band around the top portion of the stomach to restrict food intake. It has become an increasingly popular option in the battle against obesity, but some experts have worried about its safety.

21 Mar 2011

Hospital meals cost less than prison meals: Official UK report

In shocking news some British hospitals are reported to be spending as little as £1 a meal, compared with £2.10 for the average prison meal. The official figures show that the spending on hospital food has been slashed by up to two-thirds over the last five years. In some hospitals in England budgets have fallen by 62 per cent – with meals costing little more than £1.

21 Mar 2011

NTSP Charitable Fund Board announces 2011 recipients of patient care grant funding opportunities

The North Texas Specialty Physicians (NTSP) Charitable Fund Board is pleased to announce the 2011 recipients of its patient care grant funding opportunities. The recipient organizations chosen serve the community and fit within the Charitable Fund's mission of "Driving innovations in the coordination and integration of safe and effective patient care in the North Texas Region."

21 Mar 2011

Researcher reverses ageing process in bee's brain

Norwegian researcher Gro Amdam has succeeded in reversing the ageing process in the bee brain - findings which she believes may bring hope to people with dementia.

21 Mar 2011

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced results for the year ended December 31, 2010.

21 Mar 2011

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

Insmed Incorporated, a biopharmaceutical company, announced today that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of ARIKACE™ (liposomal amikacin for inhalation) in nontuberculous mycobacteria (NTM) lung infections has been cleared by the U.S. Food and Drug Administration (FDA).

21 Mar 2011

Shire announces FDA PDUFA date for FIRAZYR NDA in treatment of acute attacks of hereditary angioedema

Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.

21 Mar 2011

$CTI commences pixantrone PIX-R trial in relapsed/refractory diffuse large B-cell lymphoma$

CTI commences pixantrone PIX-R trial in relapsed/refractory diffuse large B-cell lymphoma

Cell Therapeutics, Inc. today announced that it has initiated its randomized pivotal trial of pixantrone for the treatment of relapsed/refractory diffuse large B-cell lymphoma ("DLBCL").

21 Mar 2011

Genentech's vismodegib Phase II clinical study in advanced basal cell carcinoma meets primary endpoint

Genentech, a member of the Roche Group, today announced that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results in people with advanced basal cell carcinoma (aBCC), a particularly severe and debilitating form of skin cancer.

21 Mar 2011

Lorillard responds to Tobacco Products Scientific Advisory Committee conclusions

Lorillard, Inc., the third largest manufacturer of cigarettes in the United States, announced its response to the conclusions reached at today's meeting of the Tobacco Products Scientific Advisory Committee.

19 Mar 2011

JCCF event honors Showtime Networks President with Humanitarian Award

The Jonsson Cancer Center Foundation at UCLA hosts its 16th annual Taste for a Cure Friday, April 15, 2011 at the Beverly Wilshire Hotel. This year's event honors Showtime Networks President of Entertainment, David Nevins, with the Gil Nickel Humanitarian Award.

19 Mar 2011

Food News and Research

Northwest Russian women breast milk consists of more POPs than Norwegian

WHO concerned about radiation levels in food near damaged Japanese nuclear plant

VirWall launches new UV sanitizer to eliminate bacteria, virus from communication devices

Oral desensitization with omalizumab may treat milk allergy in children

High sodium intake may increase risk of heart disease, stroke, kidney problem

Daily dose of safflower oil can help reduce cardiovascular disease

FDA accepts Arisaph's ARI-3037MO IND for phase I human clinical trial

BMY's ipilimumab Phase III study against metastatic melanoma meets primary endpoint

Watson introduces Famciclovir tablets to treat cold sores, genital herpes

Doubts raised over Lap-Band surgery in the long term: Study

Hospital meals cost less than prison meals: Official UK report

NTSP Charitable Fund Board announces 2011 recipients of patient care grant funding opportunities

Researcher reverses ageing process in bee's brain

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

Shire announces FDA PDUFA date for FIRAZYR NDA in treatment of acute attacks of hereditary angioedema

CTI commences pixantrone PIX-R trial in relapsed/refractory diffuse large B-cell lymphoma

Genentech's vismodegib Phase II clinical study in advanced basal cell carcinoma meets primary endpoint

Lorillard responds to Tobacco Products Scientific Advisory Committee conclusions

JCCF event honors Showtime Networks President with Humanitarian Award

Enhancing confidence in chemical ionization spectrometry data eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News